Research Unit

Protein Technologies Ghent

01 January 2018 → 31 December 2022
Application area
Health Tech & Pharma
Business developer
Research disciplines
  • Natural sciences
    • Artificial intelligence not elsewhere classified
    • Proteins
  • Medical and health sciences
    • Protein diagnostics
    • Proteins
    • Protein diagnostics
    • Proteins
    • Protein diagnostics
    • Proteins
  • Engineering and technology
    • Medical molecular engineering of nucleic acids and proteins
Proteomics & biopharmaceutical protein production- and delivery techniques. Protein Technologies Ghent is a consortium of research groups from UGent and VIB, each with a long-standing reputation of expertise in their respective fields. Centered around facilitating biopharmaceutical moiety discovery and development, the consortium integrates the assembled know-how from its members to accelerate the process of developing novel therapies against e.g. viral infections, microbial antibiotics resistance and cancer. These efforts inherently go hand-in-hand with the development of new supporting technologies. The consortium aims to grant access to these high-end solutions for other public institutions and the biotech & pharma-industry in Belgium and beyond. We do this by investing actively in the development of these assets into products that live up to industry-standards and subsequently offering integrated services to our network, or out-licensing the technology overall.